Metformin as firstline treatment for type 2 diabetes: are we sure?

BMJ. 2016 Jan 8:352:h6748. doi: 10.1136/bmj.h6748.

Abstract

Rémy Boussageon and colleagues ask whether metformin is bringing practical benefit to patients and question the focus on surrogate measures.

MeSH terms

  • Bias
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Metformin / administration & dosage*
  • Practice Guidelines as Topic

Substances

  • Hypoglycemic Agents
  • Metformin